Biocon
BSE: 532523 | NSE: BIOCON | ISIN: INE376G01013 | Pharmaceuticals
 |
Profit & Loss account of Biocon |
------------------- in Rs. Cr. ------------------- |
| Mar '05 | Mar '06 | Mar '07 | Mar '08 | Mar '09 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| Income | ||||||||||
| Sales Turnover | 688.28 | 728.81 | 861.53 | 860.23 | 929.90 | |||||
| Excise Duty | 37.84 | 37.18 | 36.18 | 26.24 | 25.69 | |||||
| Net Sales | 650.44 | 691.63 | 825.35 | 833.99 | 904.21 | |||||
| Other Income | 18.16 | 6.16 | 49.25 | 409.77 | -15.59 | |||||
| Stock Adjustments | 3.04 | 20.80 | 21.89 | 11.96 | 26.77 | |||||
| Total Income | 671.64 | 718.59 | 896.49 | 1,255.72 | 915.39 | |||||
| Expenditure | ||||||||||
| Raw Materials | 351.27 | 407.28 | 443.65 | 410.66 | 442.85 | |||||
| Power & Fuel Cost | 24.60 | 30.78 | 62.07 | 76.12 | 71.22 | |||||
| Employee Cost | 42.04 | 42.06 | 55.27 | 66.81 | 80.42 | |||||
| Other Manufacturing Expenses | 7.32 | 6.19 | 11.15 | 12.79 | 13.67 | |||||
| Selling and Admin Expenses | 29.52 | 37.68 | 69.76 | 87.92 | 102.71 | |||||
| Miscellaneous Expenses | 8.91 | 8.38 | 17.76 | 15.38 | 10.83 | |||||
| Preoperative Exp Capitalised | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Total Expenses | 463.66 | 532.37 | 659.66 | 669.68 | 721.70 | |||||
| Mar '05 | Mar '06 | Mar '07 | Mar '08 | Mar '09 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| Operating Profit | 189.82 | 180.06 | 187.58 | 176.27 | 209.28 | |||||
| PBDIT | 207.98 | 186.22 | 236.83 | 586.04 | 193.69 | |||||
| Interest | 2.69 | 2.48 | 8.16 | 3.09 | 4.94 | |||||
| PBDT | 205.29 | 183.74 | 228.67 | 582.95 | 188.75 | |||||
| Depreciation | 18.09 | 22.85 | 57.61 | 69.00 | 74.28 | |||||
| Other Written Off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Profit Before Tax | 187.20 | 160.89 | 171.06 | 513.95 | 114.47 | |||||
| Extra-ordinary items | 1.32 | 0.00 | 0.00 | -68.39 | 7.73 | |||||
| PBT (Post Extra-ord Items) | 188.52 | 160.89 | 171.06 | 445.56 | 122.20 | |||||
| Tax | 14.12 | 27.39 | 12.70 | 10.64 | 10.40 | |||||
| Reported Net Profit | 174.39 | 133.48 | 158.35 | 434.92 | 203.81 | |||||
| Total Value Addition | 112.40 | 125.10 | 216.02 | 259.01 | 278.85 | |||||
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Equity Dividend | 20.00 | 25.00 | 30.00 | 50.00 | 60.00 | |||||
| Corporate Dividend Tax | 2.81 | 3.51 | 5.10 | 8.50 | 10.20 | |||||
| Per share data (annualised) | ||||||||||
| Shares in issue (lakhs) | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 2,000.00 | |||||
| Earning Per Share (Rs) | 17.44 | 13.35 | 15.84 | 43.49 | 10.19 | |||||
| Equity Dividend (%) | 40.00 | 50.00 | 60.00 | 100.00 | 60.00 | |||||
| Book Value (Rs) | 69.45 | 80.18 | 94.05 | 132.72 | 68.70 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore Biocon connections | ||||||||||
| ||||||||||
